Abstract:Background: Mpox, is a zoonosis that is known to be endemic in several Central and West African countries. Recently, in 2022, it has emerged in Europe and United States, what raised the alarm to be declared in late June 2024 as a public health event of international concern. This study aimed to give insight about the recent spread of mpox in Sudan, and documents the epidemiologic situation. Methods: Through a cross-sectional design, Sudan mpox data was extracted from the disease surveillance line-list at the national level at Sudan Federal Ministry of Health. the data was customized and then analyzed using Epi Info7 software. Analysis was done using frequencies and percentages and the results presented in tables and figures. Permission and ethical approval were obtained from the Health Emergency and Epidemic Control Directorate at the Federal Ministry of Health. Results: The outbreak of mpox was confirmed after testing of initial specimens outside Sudan with positivity rate of 72%. Later the cases continued to be reported based on the clinical diagnosis and standard case definition. Out of 375 reported cases, 54.4% were males, while 45.6% were females. The age of cases ranged from one month to 78 years with majority (41.1%) of the cases were children under 5 years of age. Regarding the reported symptoms, all cases had the characteristic skin rash and 74.1% of them had fever. Other symptoms included, headache (31.5%), sore throat (30.9%) and lymphadenopathy (26.1%). For occupation, 35.7% were preschool and 10.4% were school children, 9% of cases were prisoners. Around 22 (5.8%) reported contact history with a confirmed case, while (5.6%) of the cases were imported cases. Cases were reported from 17 states with 42 affected localities (districts) with an overall attack rate of 2.36/ 100,000. The highest number of cases was reported from Gadaref (45.3%), West Darfur (25.9%), Khartoum (13.3%) and north Darfur (3.5%). In Gadaref, 146 (85.8%) of the cases were from a refugees' camp. Started in epi week 19, the outbreak peaked in week 38 and last in week 42. Conclusion: Mpox was confirmed in the new Sudan for the first time with cases reported in most of states. Although importation of the virus is hypothesized, internal hidden circulation is possible and more in-depth investigation is highly recommended. The higher rate of infection among preschool, school children and refugees, highlights the need to strengthen the prevention and control measures in schools and camps. More focus on the data completeness is required for better understanding of the disease and can be ensured by the surveillance directorate through training of staff and updating of reporting forms. Strengthening the lab capacity inside the country is a necessity to ensure testing of all the clinically diagnosed cases.

The 2024 Public Health Emergency of International Concern: A Global Failure to Control Mpox

Mpox: The alarm went off. Have we gone back to sleep?

Mpox needs a locally tailored global response

Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses

Editorial: Reasons for Increasing Global Concerns for the Spread of Mpox

Mpox continues to spread in Africa and threatens global health security

The Mpox outbreak is a public health emergency of international concern: Implications for mental health and global preparedness

Mpox Resurgence: A Multifaceted Analysis for Global Preparedness

A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: lessons learned and evolving practices

Sustained Human Outbreak of a New MPXV Clade I Lineage in the Eastern Democratic Republic of the Congo

Preliminary report on the molecular epidemiology of mpox, South Africa 2024

Democratic Republic of the Congo: a strengthened response to mpox could help revitalise the country's healthcare system

Mpox and Lessons Learned in the Light of the Recent Outbreak: A Narrative Review

Rapid regional mobile laboratory response and genomic monkeypox virus (MPXV) surveillance in seven East African Community partner states, August 2024: preparedness activities for the ongoing outbreak

Africa aims to avert an mpox pandemic

Mpox in Children and Adolescents during Multicountry Outbreak, 2022-2023

Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes

An overview of the progress made in research into the Mpox virus

Monkeypox pandemic in Sudan, surveillance epidemiologic report, 2022

Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines PART I: Insights into the virus and immune responses

Mapping the Landscape of Health Research Priorities for Effective Pandemic Preparedness in Human Mpox Virus Disease